A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity
Cell Reports · 2026-01 · 45 (1) · 116665
DOI: 10.1016/j.celrep.2025.116665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-01. Verfasst von Tirta M Djajawi und 27 weiteren Autor:innen. Beteiligte Einrichtung: Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, A…. Hauptthemen laut MEDLINE: MAP Kinase Kinase Kinases, Neoplasms, Cytokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Snow Medical, Tour de Cure, Nile Albright Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia.
- The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
- Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia; The Walter and Eliza Hall Institute of Medical Research, Par…
- Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
- The Peter MacCallum Cancer Centre, Parkville, VIC 3052, Australia.
- The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia. Electronic address: vervoort.s@wehi.edu.au.
Förderung
- Snow Medical
- Tour de Cure
- Nile Albright Research Foundation
- CSL Limited
- Cass Foundation
- Olivia Newton-John Cancer Research Institute
- National Health and Medical Research Council
Zitieren
APA
Djajawi, T. M., Huber, A., Rivera, S. M., Srivaths, A., Salehi, M., Gunay, G., Gerak, C., Neil, L., Ozaydin, O., Voulgaris, O., Al Halawani, A., Gannon, D., Khoshdoozmasouleh, N., Jenkins, L. J., Chan, K. F., Behren, A., Ernst, M., Mielke, L. A., Lelliott, E. J., …, & Kearney, C. J. (2026). A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity. Cell Reports, 45(1), 116665. https://doi.org/10.1016/j.celrep.2025.116665
Vancouver
Djajawi TM, Huber A, Rivera SM, Srivaths A, Salehi M, Gunay G, et al. A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity. Cell Reports. 2026;45(1):116665. doi:10.1016/j.celrep.2025.116665
BibTeX
@article{Djajawi2026,
author = {Djajawi, Tirta M and Huber, Anne and Rivera, Sarahi Mendoza and Srivaths, Akash and Salehi, Maede and Gunay, Gokhan and Gerak, Chloe and Neil, Liam and Ozaydin, Oliver and Voulgaris, Olivia and Al Halawani, Aleen and Gannon, Dáire and Khoshdoozmasouleh, Nooshin and Jenkins, Laura J and Chan, Kok Fei and Behren, Andreas and Ernst, Matthias and Mielke, Lisa A and Lelliott, Emily J and Dong, Hao and Feltham, Rebecca and Sutton, Vivien R and Trapani, Joseph A and Mariadason, John M and Pal, Bhupinder and Martin, Seamus J and Vervoort, Stephin J and Kearney, Conor J},
title = {A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {1},
pages = {116665},
doi = {10.1016/j.celrep.2025.116665}
}
EUVIMED